BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 04, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Alnylam preclinical data

In mice, C12-200-delivered siRNA silenced hepatic genes at doses 2 orders of magnitude lower than siRNAs delivered with LNP01, an optimized liver delivery formulation from an acrylamide- and acrylate-based library of lipid-like materials. Furthermore,...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >